A great example is brain tumor-targeted boron (10B) compounds (Figure 4) used in the boron neutron capture therapy (BNCT), in which a low energy thermal neutron beam initiates a fission reaction of 10B that is selectively accumulated into the cancer cells via GLUT1. This evidence concerns the gene SLC2A1 and cancer.